ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS

The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LAZAR, Gregory, A, DAHIYAT, Bassil, I, BERNETT, Matthew, J
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	LAZAR, Gregory, A DAHIYAT, Bassil, I BERNETT, Matthew, J
description	The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3029066B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3029066B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3029066B13</originalsourceid><addsrcrecordid>eNrjZNB29AvxdPJ38XQNVgj3DPFQ8AWy3TxdXRQ8g_1dfVydQ4I8nRUC_D39QoJ5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxgZGlgZmZk6ExEUoAOOMkog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS</title><source>esp@cenet</source><creator>LAZAR, Gregory, A ; DAHIYAT, Bassil, I ; BERNETT, Matthew, J</creator><creatorcontrib>LAZAR, Gregory, A ; DAHIYAT, Bassil, I ; BERNETT, Matthew, J</creatorcontrib><description>The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190220&DB=EPODOC&CC=EP&NR=3029066B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190220&DB=EPODOC&CC=EP&NR=3029066B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAZAR, Gregory, A</creatorcontrib><creatorcontrib>DAHIYAT, Bassil, I</creatorcontrib><creatorcontrib>BERNETT, Matthew, J</creatorcontrib><title>ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS</title><description>The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB29AvxdPJ38XQNVgj3DPFQ8AWy3TxdXRQ8g_1dfVydQ4I8nRUC_D39QoJ5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxgZGlgZmZk6ExEUoAOOMkog</recordid><startdate>20190220</startdate><enddate>20190220</enddate><creator>LAZAR, Gregory, A</creator><creator>DAHIYAT, Bassil, I</creator><creator>BERNETT, Matthew, J</creator><scope>EVB</scope></search><sort><creationdate>20190220</creationdate><title>ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS</title><author>LAZAR, Gregory, A ; DAHIYAT, Bassil, I ; BERNETT, Matthew, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3029066B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>LAZAR, Gregory, A</creatorcontrib><creatorcontrib>DAHIYAT, Bassil, I</creatorcontrib><creatorcontrib>BERNETT, Matthew, J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAZAR, Gregory, A</au><au>DAHIYAT, Bassil, I</au><au>BERNETT, Matthew, J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS</title><date>2019-02-20</date><risdate>2019</risdate><abstract>The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre ; ger
recordid	cdi_epo_espacenet_EP3029066B1
source	esp@cenet
subjects	CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES
title	ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A39%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAZAR,%20Gregory,%20A&rft.date=2019-02-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3029066B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true